Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reprogramming the tumor microenvironment with biotechnology. | Biomater Res | 2023 | 36721212 | PubTator, text mining | PubMed |
| Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells. | Immunity | 2023 | 36720219 | PubTator, text mining | PubMed |
| Extracellular acidosis restricts one-carbon metabolism and preserves T cell stemness. | Nat Metab | 2023 | 36717749 | PubTator, text mining | PubMed |
| Targeted inhibition of RBPJ transcription complex alleviates the exhaustion of CD8+ T cells in hepatocellular carcinoma. | Commun Biol | 2023 | 36717584 | PubTator, text mining | PubMed |
| Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro. | Gut | 2023 | 36717219 | PubTator, text mining | PubMed |
| Early transcriptional and epigenetic divergence of CD8+ T cells responding to acute versus chronic infection. | PLoS Biol | 2023 | 36716323 | PubTator, text mining | PubMed |
| Identification of novel anti-ZIKV drugs from viral-infection temporal gene expression profiles. | Emerg Microbes Infect | 2023 | 36715162 | PubTator, text mining | PubMed |
| Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia. | Exp Hematol Oncol | 2023 | 36707896 | PubTator, text mining | PubMed |
| Inflammatory processes involved in NASH-related hepatocellular carcinoma. | Biosci Rep | 2023 | 36691794 | PubTator, text mining | PubMed |
| PD-1 blockade and CDK4/6 inhibition augment nonoverlapping features of T cell activation in cancer. | J Exp Med | 2023 | 36688919 | PubTator, text mining | PubMed |
| STAT3 regulates CD8+ T cell differentiation and functions in cancer and acute infection. | J Exp Med | 2023 | 36688918 | PubTator, text mining | PubMed |
| BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8+ T cells. | Leukemia | 2023 | 36681742 | PubTator, text mining | PubMed |
| T cell exhaustion in malignant gliomas. | Trends Cancer | 2023 | 36681605 | PubTator, text mining | PubMed |
| PVRIG Expression Is an Independent Prognostic Factor and a New Potential Target for Immunotherapy in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 36672396 | PubTator, text mining | PubMed |
Single-Cell Profiling Comparisons of Tumor Microenvironment between Primary Advanced Lung Adenocarcinomas and Brain Metastases and Machine Learning Algorithms in Predicting Immunotherapeutic Responses. | Biomolecules | 2023 | 36671569 | PubTator, text mining | PubMed |
| Silver Nanoparticles Phytofabricated through Azadirachta indica: Anticancer, Apoptotic, and Wound-Healing Properties. | Antibiotics (Basel) | 2023 | 36671322 | PubTator, text mining | PubMed |
| Dynamic gene screening enabled identification of a 10-gene panel for early detection and progression assessment of gastric cancer. | Comput Struct Biotechnol J | 2023 | 36659923 | PubTator, text mining | PubMed |
| Unraveling the phenotypic and genomic background of behavioral plasticity and temperament in North American Angus cattle. | Genet Sel Evol | 2023 | 36658485 | PubTator, text mining | PubMed |
| Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy. | J Immunother Cancer | 2023 | 36657812 | PubTator, text mining | PubMed |
| Molecular and therapeutic effect of CRISPR in treating cancer. | Med Oncol | 2023 | 36650384 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=32